Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-04-03 | 2019-07-03 | 80441 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171501 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-10-21 | 2020-11-10 | 126796 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-07-02 | 2020-08-17 | 119319 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2017-07-24 | 2017-08-04 | 16832 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-01-22 | 2020-04-22 | 103957 |
| MYLAN-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-11-17 | 2021-02-04 | 128484 |
| MYLAN-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-12-16 | 2021-01-12 | 130219 |
| MYLAN-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-08-04 | 2020-09-22 | 121654 |
| MYLAN-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-03-15 | 2022-03-30 | 156728 |
| MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2023-01-17 | 2023-05-25 | 181289 |
| MYLAN-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2022-11-29 | 2023-01-17 | 176221 |
| MYLAN-LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-20 | 2019-09-18 | 91964 |
| GEN-CLOZAPINE | 200MG | TABLET | Resolved | 2017-03-23 | 2017-11-15 | 4063 |
| GEN-CLOZAPINE | 50MG | TABLET | Resolved | 2017-10-10 | 2017-10-21 | 24836 |
| GEN-CLOZAPINE | 100MG | TABLET | Avoided shortage | 2017-11-03 | 2017-11-23 | 28038 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |